222 related articles for article (PubMed ID: 30776641)
1. Tumor targeting peptides: novel therapeutic strategies in glioblastoma.
Raucher D
Curr Opin Pharmacol; 2019 Aug; 47():14-19. PubMed ID: 30776641
[TBL] [Abstract][Full Text] [Related]
2. Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview.
Guidotti G; Brambilla L; Rossi D
Cells; 2020 Feb; 9(2):. PubMed ID: 32093304
[TBL] [Abstract][Full Text] [Related]
3. Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma.
Wang G; Fu XL; Wang JJ; Guan R; Tang XJ
Curr Cancer Drug Targets; 2017; 17(1):17-39. PubMed ID: 27562399
[TBL] [Abstract][Full Text] [Related]
4. Targeting Protein Kinases for the Treatment of Glioblastoma Multiforme: Linking Basic Studies to Clinical Applications.
Zhou A
Curr Pharm Des; 2017 Nov; 23(29):4290-4302. PubMed ID: 28699529
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma: therapeutic challenges, what lies ahead.
Lima FR; Kahn SA; Soletti RC; Biasoli D; Alves T; da Fonseca AC; Garcia C; Romão L; Brito J; Holanda-Afonso R; Faria J; Borges H; Moura-Neto V
Biochim Biophys Acta; 2012 Dec; 1826(2):338-49. PubMed ID: 22677165
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma targeted therapy: updated approaches from recent biological insights.
Touat M; Idbaih A; Sanson M; Ligon KL
Ann Oncol; 2017 Jul; 28(7):1457-1472. PubMed ID: 28863449
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
[TBL] [Abstract][Full Text] [Related]
8. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.
He B; Jabouille A; Steri V; Johansson-Percival A; Michael IP; Kotamraju VR; Junckerstorff R; Nowak AK; Hamzah J; Lee G; Bergers G; Ganss R
J Pathol; 2018 Jun; 245(2):209-221. PubMed ID: 29603739
[TBL] [Abstract][Full Text] [Related]
9. Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes.
Yang Y; Yan Z; Wei D; Zhong J; Liu L; Zhang L; Wang F; Wei X; Xie C; Lu W; He D
Nanotechnology; 2013 Oct; 24(40):405101. PubMed ID: 24029287
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.
Krichevsky AM; Uhlmann EJ
Neurotherapeutics; 2019 Apr; 16(2):319-347. PubMed ID: 30644073
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
12. RIST: a potent new combination therapy for glioblastoma.
Nonnenmacher L; Westhoff MA; Fulda S; Karpel-Massler G; Halatsch ME; Engelke J; Simmet T; Corbacioglu S; Debatin KM
Int J Cancer; 2015 Feb; 136(4):E173-87. PubMed ID: 25123598
[TBL] [Abstract][Full Text] [Related]
13. Advances in drug development for targeted therapies for glioblastoma.
Yan G; Wang Y; Chen J; Zheng W; Liu C; Chen S; Wang L; Luo J; Li Z
Med Res Rev; 2020 Sep; 40(5):1950-1972. PubMed ID: 32445532
[TBL] [Abstract][Full Text] [Related]
14. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.
Wanjale MV; Kumar GSV
Expert Opin Drug Deliv; 2017 Jun; 14(6):811-824. PubMed ID: 27690671
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
16. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
17. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
[TBL] [Abstract][Full Text] [Related]
18. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.
Raucher D; Dragojevic S; Ryu J
Front Oncol; 2018; 8():624. PubMed ID: 30619758
[TBL] [Abstract][Full Text] [Related]
19. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.
Nadeem Abbas M; Kausar S; Wang F; Zhao Y; Cui H
Cells; 2019 Apr; 8(4):. PubMed ID: 31013819
[TBL] [Abstract][Full Text] [Related]
20. Targeting apoptosis pathways in glioblastoma.
Eisele G; Weller M
Cancer Lett; 2013 May; 332(2):335-45. PubMed ID: 21269762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]